AlphaYouML
Insider selling
Matthew L. Posard sold $2M of Halozyme Therapeutics, Inc. (HALO) stock
Matthew L. Posard, Dir of Halozyme Therapeutics, Inc. (HALO), sold 18,996 shares of HALO stock worth $2M, per an SEC Form 4 filed Sep 17, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 16, 2026, 1 day before it was made public.
HALO has moved +6.2% since the trade date, from $108.44 to $115.13 (Sep 22, 2026 close).
- Traded
- Sep 16, 2026
- Disclosed
- Sep 17, 2026
- Filing delay
- 1 day
- Price since
- +6.2%
- Role
- Dir
- Source
- SEC Form 4
More HALO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.